Tips on the management of rhinosinusitis

Journal of Respiratory Diseases

Volumn 29, Issue 9, 2008, Pages 353-359

  Boujaoude, Ziad C ^a   Bartter, Thaddeus C ^a   Pratter, Melvin R ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Allergic rhinitis; Rhinosinusitis

Indexed keywords

ACETYLSALICYLIC ACID; ADRENERGIC RECEPTOR STIMULATING AGENT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; ANTIINFLAMMATORY AGENT; AZELASTINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; COCAINE; CORTICOSTEROID; DECONGESTIVE AGENT; IMMUNOGLOBULIN E; IPRATROPIUM BROMIDE; ITRACONAZOLE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; OXYMETAZOLINE; PHENYLEPHRINE; PLACEBO;

ACUTE SINUSITIS; AGITATION; ALLERGIC RHINITIS; ALLERGY TEST; ARTICLE; ASTHMA; ATROPHIC RHINITIS; BACTERIAL INFECTION; CHRONIC DISEASE; CHRONIC RHINITIS; CLINICAL FEATURE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DROWSINESS; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG SENSITIVITY; EOSINOPHILIA; EPISTAXIS; HAY FEVER; HUMAN; IMMUNE STATUS; IMMUNOCOMPROMISED PATIENT; MAXILLA SINUSITIS; MONOTHERAPY; MORBIDITY; MUCOSAL DRYNESS; MYCOSIS; NONALLERGIC RHINITIS WITH EOSINOPHILIA SYNDROME; NOSE CONGESTION; OCCUPATIONAL DISEASE; PATHOPHYSIOLOGY; PERENNIAL RHINITIS; POSTNASAL DRIP; RESPIRATORY TRACT DISEASE; RHINITIS; RHINITIS MEDICAMENTOSA; RHINOSINUSITIS; SIDE EFFECT; TREATMENT FAILURE; UNSPECIFIED SIDE EFFECT; UPPER RESPIRATORY TRACT INFECTION; URINARY HESITANCY; VASOMOTOR RHINITIS; VIRAL RESPIRATORY TRACT INFECTION;

EID: 57149124352     PISSN: 0194259X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Schappert SM. Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 1996. Ambul Outreach. 1998:8-11.
2. Schappert SM. Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 1997. Vital Health Stat 13. 1999 Nov:i-iv, 1-39.
3. Benninger MS, Ferguson BJ, Hadley JA, et al. Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg. 2003; 129(3 suppl):S1-S32.
4. Gwaltney JM Jr. Acute community-acquired sinusitis. Clin Infect Dis. 1996;23:1209-1223.
5. Pratter MR, Bartter T, Lotano R. The role of sinus imaging in the treatment of chronic cough in adults. Chest. 1999;116:1287-1291.
6. Pratter MR, Curley FJ, DuBois J, Irwin RS. Cause and evaluation of chronic dyspnea in a pulmonary disease clinic. Arch Intern Med. 1989;149: 2277-2282.
7. Gwaltney JM Jr, Phillips CD, Miller RD, Riker DK. Computed tomographic study of the common cold. N Engl J Med. 1994;330:25-30.
8. Ebbens FA, Fokkens WJ. The mold conundrum in chronic rhinosinusitis: where do we stand today? Curr Allergy Asthma Rep. 2008;8:93-101.
9. Ray NF, Baraniuk JN, Thamer M, et al. Healthcare expenditures for sinusitis in 1996: contributions of asthma, rhinitis, and other airway disorders. J Allergy Clin Immunol. 1999;103(3pt 1):408-414.
10. Skoner DP. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol. 2001;108(1 suppl):S2-S8.
11. Marple BF. Allergic fungal rhinosinusitis: current theories and management strategies. Laryngoscope. 2001;111:1006-1019.
12. Ryan MW, Marple BF. Allergic fungal rhinosinusitis: diagnosis and management. Curr Opin Otolaryngol Head Neck Surg. 2007;15:18-22.
13. Settipane RA, Lieberman R Update on nonallergic rhinitis. Ann Allergy Asthma Immunol. 2001; 86:494-507.
14. Slavin RG. Occupational rhinitis. Ann Allergy Asthma Immunol. 2003;90(5 suppl 2):2-6.
15. Jacobs RL, Freedman PM, Boswell RN. Non-allergic rhinitis with eosinophilia (NARES syndrome). Clinical and immunologic presentation. J Allergy Clin Immunol. 1981;67:253-262.
16. Scadding GK. Rhinitis medicamentosa. Clin Exp Allergy. 1995;25:391-394.
17. Graf P. Rhinitis medicamentosa: aspects of pathophysiology and treatment. Allergy 1997;52 (40 suppl):28-34.
18. Chand MS, MacArthur CJ. Primary atrophic rhinitis: a summary of four cases and review of the literature. Otolaryngol Head Neck Surg. 1997;116: 554-558.
19. Irwin RS, Boulet LP, Cloutier MM, et al. Managing cough as a defense mechanism and as a symptom. A consensus panel report of the American College of Chest Physicians. Chest. 1998;114 (2 suppl Managing):133S-181S.
20. Pratter MR, Bartter T, Akers S, DuBois J. An algorithmic approach to chronic cough. Ann Intern Med. 1993;119:977-983.
21. Curley FJ, Irwin RS, Pratter MR, et al. Cough and the common cold. Am Rev Respir Dis. 1988; 138:305-311.
22. Stalman W, van Essen GA, van der Graaf Y, de Melker RA. Maxillary sinusitis in adults: an evaluation of placebo-controlled double-blind trials. Fam Pract. 1997;14:124-129.
23. Lindbaek M, Hjortdahl P, Johnsen UL. Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ. 1996;313:325-329.
24. Stalman W, van Essen GA, van der Graaf Y, de Melker RA. The end of antibiotic treatment in adults with acute sinusitis-like complaints in general practice? A placebo-controlled double-blind randomized doxycyoline trial. Br J Gen Pract. 1997;47: 794-799.
25. van Buchem FL, Knottnerus JA, Schrijnemaekers VJ, Peeters MF. Primary-care-based randomised placebo-controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet. 1997; 349:683-687.
26. Karageorgopoulos DE, Giannopoulou KP, Grammatikos AP, et al. Fluoroquinolones compared with beta-lactam antibiotics for the treatment of acute bacterial sinusitis: a meta-analysis of randomized controlled trials. CMAJ 2008;178:845-854.
27. Sinus and Allergy Health Partnership. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Executive Summary. Otolaryngol Head Neck Surg. 2004;130(suppl 1):S1-S45.
28. Irwin RS, Madison JM. The diagnosis and treatment of cough. N Engl J Med. 2000;343:1715-1721.
29. LaForce C, Dockhorn RJ, Prenner BM, et al. Safety and efficacy of azelastine nasal spray (Astelin NS) for seasonal allergic rhinitis: a 4-week comparative multicenter trial. Ann Allergy Asthma Immunol. 1996;76:181-188.
30. Banov CH, Lieberman P; Vasomotor Rhinitis Study Groups. Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis. Ann Allergy Asthma Immunol. 2001;86:28-35.
31. Orgel HA, Meltzer EO, Bierman CW, et al. Intranasal fluocortin butyl in patients with perennial rhinitis: a 12-month efficacy and safety study including nasal biopsy. J Allergy Clin Immunol. 1991;88:257-264.
32. Spector S, Bronsky E, Chervinsky P, et al. Multicenter, double-blind, placebo-controlled trial of triamcinolone acetonide nasal aerosol in the treatment of perennial allergic rhinitis. Ann Allergy. 1990;64:300-305.
33. Scadding GK, Lund VJ, Jacques LA, Richards DH. A placebo-controlled study of fluticasone propionate aqueous nasal spray and beclomethasone dipropionate in perennial rhinitis: efficacy in allergic and non-allergic perennial rhinitis. Clin Exp Allergy. 1995;25:737-743.
34. Ratner PH, Howland WC 3rd, Jacobs RL, et al. Relief of sinus pain and pressure with fluticasone propionate aqueous nasal spray: a placebo-controlled trial in patients with allergic rhinitis. Allergy Asthma Proc. 2002;23:259-263.
35. Gross G, Jacobs RL, Woodworth TH, et al. Comparative efficacy, safety, and effect on quality of life of triamcinolone acetonide and fluticasone propionate aqueous nasal sprays in patients with fall seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2002;89:56-62.
36. Welch MJ, Bronsky E, Findlay S, et al. Long-term safety of triamcinolone acetonide nasal aerosol for the treatment of perennial allergic rhinitis. Clin Ther. 1994; 16:253-262.
37. Meltzer EO, Orgel HA, Bronsky EA, et al. Ipratropium bromide aqueous nasal spray for patients with perennial allergic rhinitis: a study of its effect on their symptoms, quality of life, and nasal cytology. J Allergy Clin Immunol. 1992;90:242-249.
38. Dockhorn R, Aaronson D, Bronsky E, et al. Ipratropium bromide nasal spray 0.03% and beclomethasone nasal spray alone and in combination for the treatment of rhinorrhea in perennial rhinitis. Ann Allergy Asthma Immunol. 1999;82:349-359.
39. Grossman J, Banov C, Boggs P, et al. Use of ipratropium bromide nasal spray in chronic treatment of nonallergic perennial rhinitis, alone and in combination with other perennial rhinitis medications. J Allergy Clin Immunol. 1995;95(5 pt 2):1123-1127.
40. Druce HM, Spector SL, Fireman P, et al. Double-blind study of intranasal ipratropiurn bromide in nonallergic perennial rhinitis. Ann Allergy. 1992;69:53-60.
41. Nathan RA. Pharmacotherapy for allergic rhinitis: a critical review of leukotriene receptor antagonists compared with other treatments. Ann Allergy Asthma Immunol. 2003;90:182-190.
42. Ahovuo-Saloranta A, Borisenko OV, Kovanen N, et al. Antibiotics for acute maxillary sinusitis. Cochrane Database Syst Rev. 2008;16(2):CD000243.